Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical setting
Article in Multiple Sclerosis and Related Disorders (July 2023)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE)
Article in Turkish Journal of Medical Sciences (January 2023)
Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry
Article in PLOS ONE (October 2021)